DocGo Inc.: insider trades · United States · SEC (Form 4)

About DocGo Inc.

DocGo Inc. (ticker: DCGO) is a U.S.-listed healthcare services company traded on the NASDAQ in the United States. Founded in 2015 under the name Ambulnz, the company was built around a simple thesis: healthcare delivery can be more efficient when clinical care, transport logistics, and proprietary technology are combined into one operating platform. DocGo is headquartered in New York, placing it in a highly competitive U.S. healthcare market where scale, contracting discipline, and operational execution matter as much as clinical capability. The company’s business is organized around two core pillars: Mobile Health Services and Transportation Services. Mobile Health includes in-home and on-site clinical evaluations, diagnostics, triage, treatment, medication administration, and other care delivery programs that bring services closer to the patient. Transportation Services cover emergency response capabilities as well as non-emergency medical transport, including ambulance and wheelchair transport. In practice, DocGo positions itself as a bridge between telehealth and physical care delivery, using technology to dispatch teams, manage patient workflows, and coordinate services across partners. From a competitive standpoint, DocGo operates at the intersection of mobile care, virtual care, and medical transportation. That positioning is relevant because U.S. healthcare systems continue to face pressure from hospital overcrowding, staffing shortages, cost containment efforts, and the need to shift care into lower-cost settings. DocGo’s value proposition is that it can stand up contracted services quickly and operate them at scale for health systems, payers, and public-sector customers. The company’s footprint is primarily in the United States, though it also has a presence in the United Kingdom, giving it a modest international dimension. Recent developments have centered on expanding the company’s care delivery platform and broadening its service mix. In October 2025, DocGo acquired SteadyMD, a virtual care platform, to expand telehealth capabilities across all 50 states. The company also announced new programs and partnerships in late 2025 and early 2026, including longitudinal care services, care-gap closure initiatives, and additional mobile health offerings. Management commentary has emphasized growth in core operating volumes and a continued transition away from pandemic-related work toward more durable, recurring healthcare contracts. For equity investors, DocGo remains a growth-oriented healthcare platform with an asset-light, technology-enabled model, but one that still depends on contract wins, reimbursement dynamics, and disciplined margin execution.